Gibson J - Search Results

1

Role of congenital hypertrophy of the retinal pigment epithelium in the predictive diagnosis of familial adenomatous polyposis.

Morton DG, Gibson J, Macdonald F, Brown R, Haydon J, Cullen R, Rindl M, Hulten M, Neoptolemos JP, Keighley MR, et al. Morton DG, et al. Among authors: gibson j. Br J Surg. 1992 Jul;79(7):689-93. doi: 10.1002/bjs.1800790733. Br J Surg. 1992. PMID: 1322757

2

Predictive diagnosis of familial adenomatous polyposis with linked DNA markers: population based study.

MacDonald F, Morton DG, Rindl PM, Haydon J, Cullen R, Gibson J, Neoptolemos JP, Keighley MR, McKeown CM, Hultén M. MacDonald F, et al. Among authors: gibson j. BMJ. 1992 Apr 4;304(6831):869-72. doi: 10.1136/bmj.304.6831.869. BMJ. 1992. PMID: 1327364 Free PMC article.

3

Multiple myeloma: why does the disease escape from plateau phase?

Joshua DE, Brown RD, Gibson J. Joshua DE, et al. Among authors: gibson j. Br J Haematol. 1994 Dec;88(4):667-71. doi: 10.1111/j.1365-2141.1994.tb05102.x. Br J Haematol. 1994. PMID: 7819092 Review. No abstract available.

4

Measurement of free kappa and lambda chains in serum and the significance of their ratio in patients with multiple myeloma.

Nelson M, Brown RD, Gibson J, Joshua DE. Nelson M, et al. Among authors: gibson j. Br J Haematol. 1992 Jun;81(2):223-30. doi: 10.1111/j.1365-2141.1992.tb08211.x. Br J Haematol. 1992. PMID: 1643019

5

Prognostic factors in myeloma: what they tell us about the pathophysiology of the disease.

Joshua DE, Brown RD, Gibson J. Joshua DE, et al. Among authors: gibson j. Leuk Lymphoma. 1994 Nov;15(5-6):375-81. doi: 10.3109/10428199409049739. Leuk Lymphoma. 1994. PMID: 7873994 Review.

6

Mechanisms of the escape phase of myeloma.

Joshua DE, Gibson J, Brown RD. Joshua DE, et al. Among authors: gibson j. Blood Rev. 1994 Mar;8(1):13-20. doi: 10.1016/0268-960x(94)90003-5. Blood Rev. 1994. PMID: 8205006 Review.

7

Idiotypic oligonucleotide probes to detect myeloma cells by mRNA in situ hybridization.

Brown R, Luo XF, Gibson J, Morley A, Sykes P, Brisco M, Joshua D. Brown R, et al. Among authors: gibson j. Br J Haematol. 1995 May;90(1):113-8. doi: 10.1111/j.1365-2141.1995.tb03388.x. Br J Haematol. 1995. PMID: 7786772

8

Serum thymidine kinase as a prognostic indicator for patients with multiple myeloma: results from the MRC (UK) V trial.

Brown RD, Joshua DE, Nelson M, Gibson J, Dunn J, MacLennan IC. Brown RD, et al. Among authors: gibson j. Br J Haematol. 1993 Jun;84(2):238-41. doi: 10.1111/j.1365-2141.1993.tb03058.x. Br J Haematol. 1993. PMID: 8398824 Clinical Trial.

9

The labelling index of primitive plasma cells determines the clinical behaviour of patients with myelomatosis.

Joshua D, Petersen A, Brown R, Pope B, Snowdon L, Gibson J. Joshua D, et al. Among authors: gibson j. Br J Haematol. 1996 Jul;94(1):76-81. doi: 10.1046/j.1365-2141.1996.d01-1784.x. Br J Haematol. 1996. PMID: 8757512

10

Human cardiolipin as the antigen in an ELISA to detect anticardiolipin antibodies.

Brown RD, Gibson J, Wells J, Jun R, Rickard K, Kronenberg H. Brown RD, et al. Among authors: gibson j. Br J Rheumatol. 1989 Apr;28(2):109-12. doi: 10.1093/rheumatology/28.2.109. Br J Rheumatol. 1989. PMID: 2495836

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,756 results

Search Page

Filters